Comments
Genmab signs antibody research deal with Janssen Biotech
13.07.2012. | COPENHAGEN (Reuters) - Danish biopharma firm Genmab has agreed to collaborate with Janssen Biotech to create and develop antibodies using its DuoBody technology platform and will receive an upfront payment of $3.5 million, Genmab said....
